Literature DB >> 21820070

Application of the systematic "DAmP" approach to create a partially defective C. albicans mutant.

J S Finkel1, N Yudanin, J E Nett, D R Andes, A P Mitchell.   

Abstract

An understanding of gene function often relies upon creating multiple kinds of alleles. Functional analysis in Candida albicans, a major fungal pathogen, has generally included characterization of mutant strains with insertion or deletion alleles and over-expression alleles. Here we use in C. albicans another type of allele that has been employed effectively in the model yeast Saccharomyces cerevisiae, a "Decreased Abundance by mRNA Perturbation" (DAmP) allele (Yan et al., 2008). DAmP alleles are created systematically through replacement of 30 noncoding regions with nonfunctional heterologous sequences, and thus are broadly applicable. We used a DAmP allele to probe the function of Sun41, a surface protein with roles in cell wall integrity, cell-cell adherence, hyphal formation, and biofilm formation that has been suggested as a possible therapeutic target (Firon et al., 2007; Hiller et al., 2007; Norice et al., 2007). A SUN41-DAmP allele results in approximately 10-fold reduced levels of SUN41 RNA, and yields intermediate phenotypes in most assays. We report that a sun41Δ/Δ mutant is defective in biofilm formation in vivo, and that the SUN41-DAmP allele complements that defect. This finding argues that Sun41 may not be an ideal therapeutic target for biofilm inhibition, since a 90% decrease in activity has little effect on biofilm formation in vivo. We anticipate that DAmP alleles of C. albicans genes will be informative for analysis of other prospective drug targets, including essential genes.

Entities:  

Mesh:

Year:  2011        PMID: 21820070      PMCID: PMC3185220          DOI: 10.1016/j.fgb.2011.07.005

Source DB:  PubMed          Journal:  Fungal Genet Biol        ISSN: 1087-1845            Impact factor:   3.495


  38 in total

Review 1.  Relationship between switching and mating in Candida albicans.

Authors:  David R Soll; Shawn R Lockhart; Rui Zhao
Journal:  Eukaryot Cell       Date:  2003-06

2.  The Ess1 prolyl isomerase is required for growth and morphogenetic switching in Candida albicans.

Authors:  Gina Devasahayam; Vishnu Chaturvedi; Steven D Hanes
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

3.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  Evaluation of the CaMAL2 promoter for regulated expression of genes in Candida albicans.

Authors:  A C Backen; I D Broadbent; R W Fetherston; J D Rosamond; N F Schnell; M J Stark
Journal:  Yeast       Date:  2000-09-15       Impact factor: 3.239

5.  Cloning and sequencing of the Candida albicans C-4 sterol methyl oxidase gene (ERG25) and expression of an ERG25 conditional lethal mutation in Saccharomyces cerevisiae.

Authors:  M A Kennedy; T A Johnson; N D Lees; R Barbuch; J A Eckstein; M Bard
Journal:  Lipids       Date:  2000-03       Impact factor: 1.880

6.  The MET3 promoter: a new tool for Candida albicans molecular genetics.

Authors:  R S Care; J Trevethick; K M Binley; P E Sudbery
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

7.  Tetracycline-regulatable system to tightly control gene expression in the pathogenic fungus Candida albicans.

Authors:  H Nakayama; T Mio; S Nagahashi; M Kokado; M Arisawa; Y Aoki
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

8.  Gene annotation and drug target discovery in Candida albicans with a tagged transposon mutant collection.

Authors:  Julia Oh; Eula Fung; Ulrich Schlecht; Ronald W Davis; Guri Giaever; Robert P St Onge; Adam Deutschbauer; Corey Nislow
Journal:  PLoS Pathog       Date:  2010-10-07       Impact factor: 6.823

9.  Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C.albicans.

Authors:  M Andrew Uhl; Matt Biery; Nancy Craig; Alexander D Johnson
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

10.  Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis.

Authors:  Dana A Davis; Vincent M Bruno; Lucio Loza; Scott G Filler; Aaron P Mitchell
Journal:  Genetics       Date:  2002-12       Impact factor: 4.562

View more
  8 in total

1.  Candida albicans Biofilm Development and Its Genetic Control.

Authors:  Jigar V Desai; Aaron P Mitchell
Journal:  Microbiol Spectr       Date:  2015-06

Review 2.  Fungal Biofilms: Inside Out.

Authors:  Katherine Lagree; Aaron P Mitchell
Journal:  Microbiol Spectr       Date:  2017-04

3.  Shuttle vectors for facile gap repair cloning and integration into a neutral locus in Candida albicans.

Authors:  Maryam Gerami-Nejad; Lucia F Zacchi; Mark McClellan; Kathleen Matter; Judith Berman
Journal:  Microbiology       Date:  2013-01-10       Impact factor: 2.777

4.  Portrait of Candida albicans adherence regulators.

Authors:  Jonathan S Finkel; Wenjie Xu; David Huang; Elizabeth M Hill; Jigar V Desai; Carol A Woolford; Jeniel E Nett; Heather Taff; Carmelle T Norice; David R Andes; Frederick Lanni; Aaron P Mitchell
Journal:  PLoS Pathog       Date:  2012-02-16       Impact factor: 6.823

5.  Titrating Gene Function in the Human Fungal Pathogen Candida albicans through Poly-Adenosine Tract Insertion.

Authors:  Helene Tournu; Arielle Butts; Glen E Palmer
Journal:  mSphere       Date:  2019-05-22       Impact factor: 4.389

6.  Plasma Membrane Phosphatidylinositol-4-Phosphate Is Not Necessary for Candida albicans Viability yet Is Key for Cell Wall Integrity and Systemic Infection.

Authors:  Rocio Garcia-Rodas; Hayet Labbaoui; François Orange; Norma Solis; Oscar Zaragoza; Scott G Filler; Martine Bassilana; Robert A Arkowitz
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.867

7.  Bypass of Candida albicans Filamentation/Biofilm Regulators through Diminished Expression of Protein Kinase Cak1.

Authors:  Carol A Woolford; Katherine Lagree; Wenjie Xu; Tatyana Aleynikov; Hema Adhikari; Hiram Sanchez; Paul J Cullen; Frederick Lanni; David R Andes; Aaron P Mitchell
Journal:  PLoS Genet       Date:  2016-12-09       Impact factor: 5.917

8.  Target Abundance-Based Fitness Screening (TAFiS) Facilitates Rapid Identification of Target-Specific and Physiologically Active Chemical Probes.

Authors:  Arielle Butts; Christian DeJarnette; Tracy L Peters; Josie E Parker; Morgan E Kerns; Karen E Eberle; Steve L Kelly; Glen E Palmer
Journal:  mSphere       Date:  2017-10-04       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.